世界の間質性肺疾患（ILD）市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Interstitial Lung Disease (ILD) Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-4382
• 出版社/出版日：QYResearch / 2021年6月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、97ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査レポートでは、間質性肺疾患（ILD）の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（間質性肺炎、特発性肺線維症、非特異性間質性肺炎、過敏性肺炎、特発性器質性肺炎、急性間質性肺炎、剥離性間質性肺炎、その他）、用途別市場規模（大人用、子供用）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。
・市場概要
・間質性肺疾患（ILD）の市場動向
・企業の競争状況、市場シェア
・間質性肺疾患（ILD）の種類別市場規模と予測2016-2027（間質性肺炎、特発性肺線維症、非特異性間質性肺炎、過敏性肺炎、特発性器質性肺炎、急性間質性肺炎、剥離性間質性肺炎、その他）
・間質性肺疾患（ILD）の用途別市場規模と予測2016-2027（大人用、子供用）
・間質性肺疾患（ILD）の北米市場規模2016-2027（アメリカ、カナダ）
・間質性肺疾患（ILD）の欧州市場規模2016-2027（ドイツ、フランス、イギリス等）
・間質性肺疾患（ILD）のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・間質性肺疾患（ILD）の中南米市場規模2016-2027（メキシコ、ブラジル）
・間質性肺疾患（ILD）の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Boehringer Ingelheim、Bellerophon Therapeutics, Inc、Bayer、Fujirebio (Miraca)、Philips、Merck、Siemens Healthineers）
・結論

Interstitial Lung Disease (ILD), also referred to as pulmonary fibrosis or interstitial pneumonia, comprises a group of conditions characterized by varying degrees of inflammation and scarring around the tiny air sacs (alveoli) in the lungs. Interstitial Lung Disease treatment market in this report.

Market Analysis and Insights: Global Interstitial Lung Disease (ILD) Market
The global Interstitial Lung Disease (ILD) market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Interstitial Lung Disease (ILD) market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Interstitial Lung Disease (ILD) market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Interstitial Lung Disease (ILD) market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Interstitial Lung Disease (ILD) market.

Global Interstitial Lung Disease (ILD) Scope and Market Size
Interstitial Lung Disease (ILD) market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Interstitial Lung Disease (ILD) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Interstitial Pneumonia
Idiopathic Pulmonary Fibrosis
Nonspecific Interstitial Pneumonitis
Hypersensitivity Pneumonitis
Cryptogenic Organizing Pneumonia
Acute Interstitial Pneumonitis
Desquamative Interstitial Pneumonitis
Others

Segment by Application
Adults
Children

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Boehringer Ingelheim
Bellerophon Therapeutics, Inc
Bayer
Fujirebio (Miraca)
Philips
Merck
Siemens Healthineers

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Interstitial Lung Disease (ILD) Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Interstitial Pneumonia
1.2.3 Idiopathic Pulmonary Fibrosis
1.2.4 Nonspecific Interstitial Pneumonitis
1.2.5 Hypersensitivity Pneumonitis
1.2.6 Cryptogenic Organizing Pneumonia
1.2.7 Acute Interstitial Pneumonitis
1.2.8 Desquamative Interstitial Pneumonitis
1.2.9 Others
1.3 Market by Application
1.3.1 Global Interstitial Lung Disease (ILD) Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Adults
1.3.3 Children
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Interstitial Lung Disease (ILD) Market Perspective (2016-2027)
2.2 Interstitial Lung Disease (ILD) Growth Trends by Regions
2.2.1 Interstitial Lung Disease (ILD) Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Interstitial Lung Disease (ILD) Historic Market Share by Regions (2016-2021)
2.2.3 Interstitial Lung Disease (ILD) Forecasted Market Size by Regions (2022-2027)
2.3 Interstitial Lung Disease (ILD) Industry Dynamic
2.3.1 Interstitial Lung Disease (ILD) Market Trends
2.3.2 Interstitial Lung Disease (ILD) Market Drivers
2.3.3 Interstitial Lung Disease (ILD) Market Challenges
2.3.4 Interstitial Lung Disease (ILD) Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Interstitial Lung Disease (ILD) Players by Revenue
3.1.1 Global Top Interstitial Lung Disease (ILD) Players by Revenue (2016-2021)
3.1.2 Global Interstitial Lung Disease (ILD) Revenue Market Share by Players (2016-2021)
3.2 Global Interstitial Lung Disease (ILD) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Interstitial Lung Disease (ILD) Revenue
3.4 Global Interstitial Lung Disease (ILD) Market Concentration Ratio
3.4.1 Global Interstitial Lung Disease (ILD) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Interstitial Lung Disease (ILD) Revenue in 2020
3.5 Interstitial Lung Disease (ILD) Key Players Head office and Area Served
3.6 Key Players Interstitial Lung Disease (ILD) Product Solution and Service
3.7 Date of Enter into Interstitial Lung Disease (ILD) Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Interstitial Lung Disease (ILD) Breakdown Data by Type
4.1 Global Interstitial Lung Disease (ILD) Historic Market Size by Type (2016-2021)
4.2 Global Interstitial Lung Disease (ILD) Forecasted Market Size by Type (2022-2027)

5 Interstitial Lung Disease (ILD) Breakdown Data by Application
5.1 Global Interstitial Lung Disease (ILD) Historic Market Size by Application (2016-2021)
5.2 Global Interstitial Lung Disease (ILD) Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Interstitial Lung Disease (ILD) Market Size (2016-2027)
6.2 North America Interstitial Lung Disease (ILD) Market Size by Type
6.2.1 North America Interstitial Lung Disease (ILD) Market Size by Type (2016-2021)
6.2.2 North America Interstitial Lung Disease (ILD) Market Size by Type (2022-2027)
6.2.3 North America Interstitial Lung Disease (ILD) Market Size by Type (2016-2027)
6.3 North America Interstitial Lung Disease (ILD) Market Size by Application
6.3.1 North America Interstitial Lung Disease (ILD) Market Size by Application (2016-2021)
6.3.2 North America Interstitial Lung Disease (ILD) Market Size by Application (2022-2027)
6.3.3 North America Interstitial Lung Disease (ILD) Market Size by Application (2016-2027)
6.4 North America Interstitial Lung Disease (ILD) Market Size by Country
6.4.1 North America Interstitial Lung Disease (ILD) Market Size by Country (2016-2021)
6.4.2 North America Interstitial Lung Disease (ILD) Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Interstitial Lung Disease (ILD) Market Size (2016-2027)
7.2 Europe Interstitial Lung Disease (ILD) Market Size by Type
7.2.1 Europe Interstitial Lung Disease (ILD) Market Size by Type (2016-2021)
7.2.2 Europe Interstitial Lung Disease (ILD) Market Size by Type (2022-2027)
7.2.3 Europe Interstitial Lung Disease (ILD) Market Size by Type (2016-2027)
7.3 Europe Interstitial Lung Disease (ILD) Market Size by Application
7.3.1 Europe Interstitial Lung Disease (ILD) Market Size by Application (2016-2021)
7.3.2 Europe Interstitial Lung Disease (ILD) Market Size by Application (2022-2027)
7.3.3 Europe Interstitial Lung Disease (ILD) Market Size by Application (2016-2027)
7.4 Europe Interstitial Lung Disease (ILD) Market Size by Country
7.4.1 Europe Interstitial Lung Disease (ILD) Market Size by Country (2016-2021)
7.4.2 Europe Interstitial Lung Disease (ILD) Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Interstitial Lung Disease (ILD) Market Size (2016-2027)
8.2 Asia-Pacific Interstitial Lung Disease (ILD) Market Size by Type
8.2.1 Asia-Pacific Interstitial Lung Disease (ILD) Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Interstitial Lung Disease (ILD) Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Interstitial Lung Disease (ILD) Market Size by Type (2016-2027)
8.3 Asia-Pacific Interstitial Lung Disease (ILD) Market Size by Application
8.3.1 Asia-Pacific Interstitial Lung Disease (ILD) Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Interstitial Lung Disease (ILD) Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Interstitial Lung Disease (ILD) Market Size by Application (2016-2027)
8.4 Asia-Pacific Interstitial Lung Disease (ILD) Market Size by Region
8.4.1 Asia-Pacific Interstitial Lung Disease (ILD) Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Interstitial Lung Disease (ILD) Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Interstitial Lung Disease (ILD) Market Size (2016-2027)
9.2 Latin America Interstitial Lung Disease (ILD) Market Size by Type
9.2.1 Latin America Interstitial Lung Disease (ILD) Market Size by Type (2016-2021)
9.2.2 Latin America Interstitial Lung Disease (ILD) Market Size by Type (2022-2027)
9.2.3 Latin America Interstitial Lung Disease (ILD) Market Size by Type (2016-2027)
9.3 Latin America Interstitial Lung Disease (ILD) Market Size by Application
9.3.1 Latin America Interstitial Lung Disease (ILD) Market Size by Application (2016-2021)
9.3.2 Latin America Interstitial Lung Disease (ILD) Market Size by Application (2022-2027)
9.3.3 Latin America Interstitial Lung Disease (ILD) Market Size by Application (2016-2027)
9.4 Latin America Interstitial Lung Disease (ILD) Market Size by Country
9.4.1 Latin America Interstitial Lung Disease (ILD) Market Size by Country (2016-2021)
9.4.2 Latin America Interstitial Lung Disease (ILD) Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Interstitial Lung Disease (ILD) Market Size (2016-2027)
10.2 Middle East & Africa Interstitial Lung Disease (ILD) Market Size by Type
10.2.1 Middle East & Africa Interstitial Lung Disease (ILD) Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Interstitial Lung Disease (ILD) Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Interstitial Lung Disease (ILD) Market Size by Type (2016-2027)
10.3 Middle East & Africa Interstitial Lung Disease (ILD) Market Size by Application
10.3.1 Middle East & Africa Interstitial Lung Disease (ILD) Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Interstitial Lung Disease (ILD) Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Interstitial Lung Disease (ILD) Market Size by Application (2016-2027)
10.4 Middle East & Africa Interstitial Lung Disease (ILD) Market Size by Country
10.4.1 Middle East & Africa Interstitial Lung Disease (ILD) Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Interstitial Lung Disease (ILD) Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Boehringer Ingelheim
11.1.1 Boehringer Ingelheim Company Details
11.1.2 Boehringer Ingelheim Business Overview
11.1.3 Boehringer Ingelheim Interstitial Lung Disease (ILD) Introduction
11.1.4 Boehringer Ingelheim Revenue in Interstitial Lung Disease (ILD) Business (2016-2021)
11.1.5 Boehringer Ingelheim Recent Development
11.2 Bellerophon Therapeutics, Inc
11.2.1 Bellerophon Therapeutics, Inc Company Details
11.2.2 Bellerophon Therapeutics, Inc Business Overview
11.2.3 Bellerophon Therapeutics, Inc Interstitial Lung Disease (ILD) Introduction
11.2.4 Bellerophon Therapeutics, Inc Revenue in Interstitial Lung Disease (ILD) Business (2016-2021)
11.2.5 Bellerophon Therapeutics, Inc Recent Development
11.3 Bayer
11.3.1 Bayer Company Details
11.3.2 Bayer Business Overview
11.3.3 Bayer Interstitial Lung Disease (ILD) Introduction
11.3.4 Bayer Revenue in Interstitial Lung Disease (ILD) Business (2016-2021)
11.3.5 Bayer Recent Development
11.4 Fujirebio (Miraca)
11.4.1 Fujirebio (Miraca) Company Details
11.4.2 Fujirebio (Miraca) Business Overview
11.4.3 Fujirebio (Miraca) Interstitial Lung Disease (ILD) Introduction
11.4.4 Fujirebio (Miraca) Revenue in Interstitial Lung Disease (ILD) Business (2016-2021)
11.4.5 Fujirebio (Miraca) Recent Development
11.5 Philips
11.5.1 Philips Company Details
11.5.2 Philips Business Overview
11.5.3 Philips Interstitial Lung Disease (ILD) Introduction
11.5.4 Philips Revenue in Interstitial Lung Disease (ILD) Business (2016-2021)
11.5.5 Philips Recent Development
11.6 Merck
11.6.1 Merck Company Details
11.6.2 Merck Business Overview
11.6.3 Merck Interstitial Lung Disease (ILD) Introduction
11.6.4 Merck Revenue in Interstitial Lung Disease (ILD) Business (2016-2021)
11.6.5 Merck Recent Development
11.7 Siemens Healthineers
11.7.1 Siemens Healthineers Company Details
11.7.2 Siemens Healthineers Business Overview
11.7.3 Siemens Healthineers Interstitial Lung Disease (ILD) Introduction
11.7.4 Siemens Healthineers Revenue in Interstitial Lung Disease (ILD) Business (2016-2021)
11.7.5 Siemens Healthineers Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Interstitial Lung Disease (ILD) Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Interstitial Pneumonia
Table 3. Key Players of Idiopathic Pulmonary Fibrosis
Table 4. Key Players of Nonspecific Interstitial Pneumonitis
Table 5. Key Players of Hypersensitivity Pneumonitis
Table 6. Key Players of Cryptogenic Organizing Pneumonia
Table 7. Key Players of Acute Interstitial Pneumonitis
Table 8. Key Players of Desquamative Interstitial Pneumonitis
Table 9. Key Players of Others
Table 10. Global Interstitial Lung Disease (ILD) Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 11. Global Interstitial Lung Disease (ILD) Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 12. Global Interstitial Lung Disease (ILD) Market Size by Regions (2016-2021) & (US$ Million)
Table 13. Global Interstitial Lung Disease (ILD) Market Share by Regions (2016-2021)
Table 14. Global Interstitial Lung Disease (ILD) Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 15. Global Interstitial Lung Disease (ILD) Market Share by Regions (2022-2027)
Table 16. Interstitial Lung Disease (ILD) Market Trends
Table 17. Interstitial Lung Disease (ILD) Market Drivers
Table 18. Interstitial Lung Disease (ILD) Market Challenges
Table 19. Interstitial Lung Disease (ILD) Market Restraints
Table 20. Global Interstitial Lung Disease (ILD) Revenue by Players (2016-2021) & (US$ Million)
Table 21. Global Interstitial Lung Disease (ILD) Market Share by Players (2016-2021)
Table 22. Global Top Interstitial Lung Disease (ILD) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Interstitial Lung Disease (ILD) as of 2020)
Table 23. Ranking of Global Top Interstitial Lung Disease (ILD) Companies by Revenue (US$ Million) in 2020
Table 24. Global 5 Largest Players Market Share by Interstitial Lung Disease (ILD) Revenue (CR5 and HHI) & (2016-2021)
Table 25. Key Players Headquarters and Area Served
Table 26. Key Players Interstitial Lung Disease (ILD) Product Solution and Service
Table 27. Date of Enter into Interstitial Lung Disease (ILD) Market
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Interstitial Lung Disease (ILD) Market Size by Type (2016-2021) (US$ Million)
Table 30. Global Interstitial Lung Disease (ILD) Revenue Market Share by Type (2016-2021)
Table 31. Global Interstitial Lung Disease (ILD) Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 32. Global Interstitial Lung Disease (ILD) Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 33. Global Interstitial Lung Disease (ILD) Market Size Share by Application (2016-2021) & (US$ Million)
Table 34. Global Interstitial Lung Disease (ILD) Revenue Market Share by Application (2016-2021)
Table 35. Global Interstitial Lung Disease (ILD) Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 36. Global Interstitial Lung Disease (ILD) Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 37. North America Interstitial Lung Disease (ILD) Market Size by Type (2016-2021) (US$ Million)
Table 38. North America Interstitial Lung Disease (ILD) Market Size by Type (2022-2027) & (US$ Million)
Table 39. North America Interstitial Lung Disease (ILD) Market Size by Application (2016-2021) (US$ Million)
Table 40. North America Interstitial Lung Disease (ILD) Market Size by Application (2022-2027) & (US$ Million)
Table 41. North America Interstitial Lung Disease (ILD) Market Size by Country (2016-2021) & (US$ Million)
Table 42. North America Interstitial Lung Disease (ILD) Market Size by Country (2022-2027) & (US$ Million)
Table 43. Europe Interstitial Lung Disease (ILD) Market Size by Type (2016-2021) (US$ Million)
Table 44. Europe Interstitial Lung Disease (ILD) Market Size by Type (2022-2027) & (US$ Million)
Table 45. Europe Interstitial Lung Disease (ILD) Market Size by Application (2016-2021) (US$ Million)
Table 46. Europe Interstitial Lung Disease (ILD) Market Size by Application (2022-2027) & (US$ Million)
Table 47. Europe Interstitial Lung Disease (ILD) Market Size by Country (2016-2021) & (US$ Million)
Table 48. Europe Interstitial Lung Disease (ILD) Market Size by Country (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Interstitial Lung Disease (ILD) Market Size by Type (2016-2021) (US$ Million)
Table 50. Asia-Pacific Interstitial Lung Disease (ILD) Market Size by Type (2022-2027) & (US$ Million)
Table 51. Asia-Pacific Interstitial Lung Disease (ILD) Market Size by Application (2016-2021) (US$ Million)
Table 52. Asia-Pacific Interstitial Lung Disease (ILD) Market Size by Application (2022-2027) & (US$ Million)
Table 53. Asia-Pacific Interstitial Lung Disease (ILD) Market Size by Region (2016-2021) & (US$ Million)
Table 54. Asia-Pacific Interstitial Lung Disease (ILD) Market Size by Region (2022-2027) & (US$ Million)
Table 55. Latin America Interstitial Lung Disease (ILD) Market Size by Type (2016-2021) (US$ Million)
Table 56. Latin America Interstitial Lung Disease (ILD) Market Size by Type (2022-2027) & (US$ Million)
Table 57. Latin America Interstitial Lung Disease (ILD) Market Size by Application (2016-2021) (US$ Million)
Table 58. Latin America Interstitial Lung Disease (ILD) Market Size by Application (2022-2027) & (US$ Million)
Table 59. Latin America Interstitial Lung Disease (ILD) Market Size by Country (2016-2021) & (US$ Million)
Table 60. Latin America Interstitial Lung Disease (ILD) Market Size by Country (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Interstitial Lung Disease (ILD) Market Size by Type (2016-2021) (US$ Million)
Table 62. Middle East & Africa Interstitial Lung Disease (ILD) Market Size by Type (2022-2027) & (US$ Million)
Table 63. Middle East & Africa Interstitial Lung Disease (ILD) Market Size by Application (2016-2021) (US$ Million)
Table 64. Middle East & Africa Interstitial Lung Disease (ILD) Market Size by Application (2022-2027) & (US$ Million)
Table 65. Middle East & Africa Interstitial Lung Disease (ILD) Market Size by Country (2016-2021) & (US$ Million)
Table 66. Middle East & Africa Interstitial Lung Disease (ILD) Market Size by Country (2022-2027) & (US$ Million)
Table 67. Boehringer Ingelheim Company Details
Table 68. Boehringer Ingelheim Business Overview
Table 69. Boehringer Ingelheim Interstitial Lung Disease (ILD) Product
Table 70. Boehringer Ingelheim Revenue in Interstitial Lung Disease (ILD) Business (2016-2021) & (US$ Million)
Table 71. Boehringer Ingelheim Recent Development
Table 72. Bellerophon Therapeutics, Inc Company Details
Table 73. Bellerophon Therapeutics, Inc Business Overview
Table 74. Bellerophon Therapeutics, Inc Interstitial Lung Disease (ILD) Product
Table 75. Bellerophon Therapeutics, Inc Revenue in Interstitial Lung Disease (ILD) Business (2016-2021) & (US$ Million)
Table 76. Bellerophon Therapeutics, Inc Recent Development
Table 77. Bayer Company Details
Table 78. Bayer Business Overview
Table 79. Bayer Interstitial Lung Disease (ILD) Product
Table 80. Bayer Revenue in Interstitial Lung Disease (ILD) Business (2016-2021) & (US$ Million)
Table 81. Bayer Recent Development
Table 82. Fujirebio (Miraca) Company Details
Table 83. Fujirebio (Miraca) Business Overview
Table 84. Fujirebio (Miraca) Interstitial Lung Disease (ILD) Product
Table 85. Fujirebio (Miraca) Revenue in Interstitial Lung Disease (ILD) Business (2016-2021) & (US$ Million)
Table 86. Fujirebio (Miraca) Recent Development
Table 87. Philips Company Details
Table 88. Philips Business Overview
Table 89. Philips Interstitial Lung Disease (ILD) Product
Table 90. Philips Revenue in Interstitial Lung Disease (ILD) Business (2016-2021) & (US$ Million)
Table 91. Philips Recent Development
Table 92. Merck Company Details
Table 93. Merck Business Overview
Table 94. Merck Interstitial Lung Disease (ILD) Product
Table 95. Merck Revenue in Interstitial Lung Disease (ILD) Business (2016-2021) & (US$ Million)
Table 96. Merck Recent Development
Table 97. Siemens Healthineers Company Details
Table 98. Siemens Healthineers Business Overview
Table 99. Siemens Healthineers Interstitial Lung Disease (ILD) Product
Table 100. Siemens Healthineers Revenue in Interstitial Lung Disease (ILD) Business (2016-2021) & (US$ Million)
Table 101. Siemens Healthineers Recent Development
Table 102. Research Programs/Design for This Report
Table 103. Key Data Information from Secondary Sources
Table 104. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Interstitial Lung Disease (ILD) Market Share by Type: 2020 VS 2027
Figure 2. Interstitial Pneumonia Features
Figure 3. Idiopathic Pulmonary Fibrosis Features
Figure 4. Nonspecific Interstitial Pneumonitis Features
Figure 5. Hypersensitivity Pneumonitis Features
Figure 6. Cryptogenic Organizing Pneumonia Features
Figure 7. Acute Interstitial Pneumonitis Features
Figure 8. Desquamative Interstitial Pneumonitis Features
Figure 9. Others Features
Figure 10. Global Interstitial Lung Disease (ILD) Market Share by Application: 2020 VS 2027
Figure 11. Adults Case Studies
Figure 12. Children Case Studies
Figure 13. Interstitial Lung Disease (ILD) Report Years Considered
Figure 14. Global Interstitial Lung Disease (ILD) Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 15. Global Interstitial Lung Disease (ILD) Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 16. Global Interstitial Lung Disease (ILD) Market Share by Regions: 2020 VS 2027
Figure 17. Global Interstitial Lung Disease (ILD) Market Share by Regions (2022-2027)
Figure 18. Global Interstitial Lung Disease (ILD) Market Share by Players in 2020
Figure 19. Global Top Interstitial Lung Disease (ILD) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Interstitial Lung Disease (ILD) as of 2020
Figure 20. The Top 10 and 5 Players Market Share by Interstitial Lung Disease (ILD) Revenue in 2020
Figure 21. Global Interstitial Lung Disease (ILD) Revenue Market Share by Type (2016-2021)
Figure 22. Global Interstitial Lung Disease (ILD) Revenue Market Share by Type (2022-2027)
Figure 23. North America Interstitial Lung Disease (ILD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. North America Interstitial Lung Disease (ILD) Market Share by Type (2016-2027)
Figure 25. North America Interstitial Lung Disease (ILD) Market Share by Application (2016-2027)
Figure 26. North America Interstitial Lung Disease (ILD) Market Share by Country (2016-2027)
Figure 27. United States Interstitial Lung Disease (ILD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Canada Interstitial Lung Disease (ILD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Europe Interstitial Lung Disease (ILD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Europe Interstitial Lung Disease (ILD) Market Share by Type (2016-2027)
Figure 31. Europe Interstitial Lung Disease (ILD) Market Share by Application (2016-2027)
Figure 32. Europe Interstitial Lung Disease (ILD) Market Share by Country (2016-2027)
Figure 33. Germany Interstitial Lung Disease (ILD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. France Interstitial Lung Disease (ILD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. U.K. Interstitial Lung Disease (ILD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Italy Interstitial Lung Disease (ILD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Russia Interstitial Lung Disease (ILD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Nordic Interstitial Lung Disease (ILD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Asia-Pacific Interstitial Lung Disease (ILD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Asia-Pacific Interstitial Lung Disease (ILD) Market Share by Type (2016-2027)
Figure 41. Asia-Pacific Interstitial Lung Disease (ILD) Market Share by Application (2016-2027)
Figure 42. Asia-Pacific Interstitial Lung Disease (ILD) Market Share by Region (2016-2027)
Figure 43. China Interstitial Lung Disease (ILD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Japan Interstitial Lung Disease (ILD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. South Korea Interstitial Lung Disease (ILD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Southeast Asia Interstitial Lung Disease (ILD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. India Interstitial Lung Disease (ILD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Australia Interstitial Lung Disease (ILD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Latin America Interstitial Lung Disease (ILD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Latin America Interstitial Lung Disease (ILD) Market Share by Type (2016-2027)
Figure 51. Latin America Interstitial Lung Disease (ILD) Market Share by Application (2016-2027)
Figure 52. Latin America Interstitial Lung Disease (ILD) Market Share by Country (2016-2027)
Figure 53. Mexico Interstitial Lung Disease (ILD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Brazil Interstitial Lung Disease (ILD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Middle East & Africa Interstitial Lung Disease (ILD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Middle East & Africa Interstitial Lung Disease (ILD) Market Share by Type (2016-2027)
Figure 57. Middle East & Africa Interstitial Lung Disease (ILD) Market Share by Application (2016-2027)
Figure 58. Middle East & Africa Interstitial Lung Disease (ILD) Market Share by Country (2016-2027)
Figure 59. Turkey Interstitial Lung Disease (ILD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Saudi Arabia Interstitial Lung Disease (ILD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. UAE Interstitial Lung Disease (ILD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 62. Boehringer Ingelheim Revenue Growth Rate in Interstitial Lung Disease (ILD) Business (2016-2021)
Figure 63. Bellerophon Therapeutics, Inc Revenue Growth Rate in Interstitial Lung Disease (ILD) Business (2016-2021)
Figure 64. Bayer Revenue Growth Rate in Interstitial Lung Disease (ILD) Business (2016-2021)
Figure 65. Fujirebio (Miraca) Revenue Growth Rate in Interstitial Lung Disease (ILD) Business (2016-2021)
Figure 66. Philips Revenue Growth Rate in Interstitial Lung Disease (ILD) Business (2016-2021)
Figure 67. Merck Revenue Growth Rate in Interstitial Lung Disease (ILD) Business (2016-2021)
Figure 68. Siemens Healthineers Revenue Growth Rate in Interstitial Lung Disease (ILD) Business (2016-2021)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed

以下、関連資料のご紹介

世界の肺・気道疾患治療市場規模・現状・予測（2021年-2027年）

Global Lung Pulmonary Airway Disease Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4446 2021年6月 99Pages
QYResearch社発行の本調査レポートでは、肺・気道疾患治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（気管支拡張薬、細胞毒性薬、抗生物質、その他）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジ...

世界の間質性肺炎市場規模・現状・予測（2021年-2027年）

Global Interstitial Pneumonia Market Size, Status and Forecast 2021-2027
QFJ1-4383 2021年6月 97Pages
QYResearch社発行の本調査レポートでは、間質性肺炎の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（一般間質性肺炎、非特異性間質性肺炎、剥離性間質性肺炎、その他）、用途別市場規模（大人用、子供用）、主要地域別市場規模（北米、アメリカ、欧州、ア...

世界の遺伝子治療医薬品（GTMP）市場規模・現状・予測（2021年-2027年）

Global Gene Therapy Medicinal Products (GTMP) Market Size, Status and Forecast 2021-2027
QFJ1-5750 2021年6月 95Pages
QYResearch社発行の本調査レポートでは、遺伝子治療医薬品（GTMP）の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（経口、注射）、用途別市場規模（がん、単発性、感染症、循環器疾患、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、...

世界の肺がん分子診断市場規模・現状・予測（2021年-2027年）

Global Lung Cancer Molecular Diagnostics Market Size, Status and Forecast 2021-2027
QFJ1-4443 2021年6月 108Pages
QYResearch社発行の本調査レポートでは、肺がん分子診断の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（PCR、FISH、DNAシーケンシング、ジーンチップ）、用途別市場規模（臨床診断、薬物スクリーニング、研究）、主要地域別市場規模（北米、ア...

世界の非小細胞肺がん治療薬市場規模・現状・予測（2021年-2027年）

Global Non-small Cell Lung Cancer Drugs Market Size, Status and Forecast 2021-2027
QFJ1-5895 2021年6月 99Pages
QYResearch社発行の本調査レポートでは、非小細胞肺がん治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（生物製剤、小分子標的療法、化学療法、その他）、用途別市場規模（肺腺癌、肺扁平上皮癌、大細胞肺癌）、主要地域別市場規模（北米、アメリカ...

世界の肺がん治療市場規模・現状・予測（2021年-2027年）

Global Lung Cancer Therapy Market Size, Status and Forecast 2021-2027
QFJ1-4445 2021年6月 109Pages
QYResearch社発行の本調査レポートでは、肺がん治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（放射線療法、化学療法、標的療法、免疫療法）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本...

世界の3D動脈スピンラベル標識法(3D ASL)市場規模・現状・予測（2021年-2027年）

Global 3D Arterial Spin Labeling(3D ASL) Market Size, Status and Forecast 2021-2027
QFJ1-5054 2021年6月 89Pages
QYResearch社発行の本調査レポートでは、3D動脈スピンラベル標識法(3D ASL)の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（CASL、PASL）、用途別市場規模（腫瘍、脳血管障害、神経変性疾患、パーキンソン病）、主要地域別市場規模（北...

世界のゴーシェ病＆ポンペ病酵素補充療法（ERT）市場規模・現状・予測（2021年-2027年）

Global Gaucher and Pompe Diseases Enzyme Replacement Therapy (ERT) Market Size, Status and Forecast 2021-2027
QFJ1-4244 2021年6月 109Pages
QYResearch社発行の本調査レポートでは、ゴーシェ病＆ポンペ病酵素補充療法（ERT）の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ゴーシェ病、ポンペ病）、用途別市場規模（乳児、子供、大人）、主要地域別市場規模（北米、アメリカ、欧州、アジア、...

世界の肺がん治療薬市場規模・現状・予測（2021年-2027年）

Global Lung Cancer Therapeutics Market Size, Status and Forecast 2021-2027
QFJ1-4444 2021年6月 106Pages
QYResearch社発行の本調査レポートでは、肺がん治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（標的療法、免疫療法、化学療法、放射線療法、その他）、用途別市場規模（非小細胞肺がん（NSCLC）、小細胞肺がん（SCLC））、主要地域別市場...

世界のALK陽性肺がん治療市場規模・現状・予測（2021年-2027年）

Global ALK Positive Lung Cancer Treatment Market Size, Status and Forecast 2021-2027
QFJ1-5075 2021年6月 97Pages
QYResearch社発行の本調査レポートでは、ALK陽性肺がん治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（クリゾチニブ、アレクチニブ、セリチニブ、ブリグチニブ、その他）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、ア...

世界の間質性肺炎市場規模・現状・予測（2021年-2027年） Interstitial pneumonia is a disease in which the mesh-like walls of the alveoli become inflamed. The pleura (a thin covering that protects and cushions the lungs and the individual lobes of the lungs) might become inflamed as well. Interstitial Pneumonia treatment market in this report. Market Analy…
極低炭素鋼のグローバル市場調査 2019年 The global Interstitial Free Steels market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Interstitial Free Steels volume and value at global level, regional level and company level. From a global perspec…
世界の過敏性肺炎治療市場規模・現状・予測（2021年-2027年） Hypersensitivity pneumonitis is a complex syndrome caused due to exposure to a variety of organic particles. Market Analysis and Insights: Global Hypersensitivity Pneumonitis Treatment Market The global Hypersensitivity Pneumonitis Treatment market size is projected to reach US$ XX million by 2027, …
世界の肺・気道疾患治療市場規模・現状・予測（2021年-2027年） Lung (Pulmonary) Airway Disease include bronchiectasis, asthma and COPD.Disease narrow down or block the airways. Such breathing problems caused due to Lung (Pulmonary) Airway Disease may inhibit the body receiving sufficient oxygen. Market Analysis and Insights: Global Lung Pulmonary Airway Disease…
世界の特発性肺線維症治療市場規模・現状・予測（2021年-2027年） Idiopathic Pulmonary Fibrosis Treatment is treatment work on a lung disease which causes the tissue in your lungs to become stiff. Market Analysis and Insights: Global Idiopathic Pulmonary Fibrosis Treatment Market The global Idiopathic Pulmonary Fibrosis Treatment market size is projected to reach…